Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Relationship between doses to anatomical structures and erectile dysfunction after radiotherapy for prostate cancer: A systematic review].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Same author

[Stereotactic ablative body radiotherapy: Which machine for which therapeutic indication? A focus on prostate cancer].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2019
Same author

[Management of neuroendocrine prostate carcinoma: Literature review].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2016
Same author

Potential interest of developing an integrated boost dose escalation for stereotactic irradiation of primary prostate cancer.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2013
Same author

[Pelvic irradiation in prostate cancer: what place for what volumes?].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2013
Same author

Radiotherapy of the pancreas: state of the art in 2012.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2012
Same journal

Comparative study of interstitial brachytherapy and intensity-modulated radiotherapy as tumour bed boost after conservative surgery for breast cancer: Toxicity and cosmetic outcomes.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatment.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Factors affecting the stability of deep inspiration breath-holding in radiotherapy for left-sided breast cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Incidence and outcomes of radiation-induced sarcomas following radiotherapy for low-grade non-Hodgkin lymphomas: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining
07:43

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining

Published on: May 9, 2025

[Primary liver cancer].

M Quivrin1, F Mornex, C Enachescu

  • 1Département de radiothérapie, Centre Georges-François-Leclerc, Dijon, France. Magali.quivrin@gmail.com

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|December 7, 2010
PubMed
Summary
This summary is machine-generated.

Primary liver cancer poses significant challenges due to rising incidence and poor outcomes. Advanced radiotherapy offers a promising non-invasive treatment for inoperable patients, achieving high local control rates.

More Related Videos

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Related Experiment Videos

Last Updated: Jun 6, 2026

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining
07:43

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining

Published on: May 9, 2025

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Area of Science:

  • Hepatology
  • Oncology
  • Radiation Oncology

Context:

  • Primary liver cancer presents a growing global health challenge with limited treatment options for advanced stages.
  • Surgical interventions are only suitable for a small percentage of patients, highlighting the need for alternative therapies.
  • Early detection and risk factor management are crucial components of current standard care for liver cancer.

Purpose:

  • To review the current landscape of primary liver cancer treatment, focusing on the role and efficacy of radiotherapy.
  • To highlight advancements in stereotactic radiotherapy for managing non-operable liver tumors.
  • To assess the potential of radiotherapy in improving outcomes for patients with poor prognostic factors.

Summary:

  • Surgical resection and liver transplantation are curative for localized primary liver cancer but applicable to less than 20% of patients.
  • External radiotherapy shows promise for non-operable cases, while stereotactic radiotherapy offers high local control with acceptable toxicity.
  • Emerging radiotherapy techniques present a viable option for treating liver tumors, including those with adverse prognostic indicators.

Impact:

  • Radiotherapy, particularly stereotactic radiotherapy, expands therapeutic options for primary liver cancer patients, especially those ineligible for surgery.
  • Improved local control rates with advanced radiotherapy can enhance the prognosis for patients with challenging liver tumors.
  • This review underscores the importance of considering radiotherapy in the multidisciplinary management of primary liver cancer.